Publicaciones - IR Sant Pau

Buscar

01/06/2024 Global cooperation and early access-clinical outcomes matter

Tibau, A, Kesselheim, AS. Global cooperation and early access-clinical outcomes matter. LANCET ONCOLOGY. 2024; 25(6)DOI:10.1016/S1470-2045(24)00210-9. PMID:38754452. IF:35.900(Q1/1D).

01/06/2024 Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM). JOURNAL OF NEURO-ONCOLOGY. 2024; 168(2)DOI:10.1007/s11060-024-04668-5. PMID:38630385. IF:3.100(Q2/4D).

01/06/2024 Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies

Tibau, A, Hwang, TJ, Avorn, J, Kesselheim, AS. Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study

Serda, PC, Cullell, BM, Castet, F, Gatell, AP, Fernandez, PR, Fernandez, J, Nadal, TS, Mateo, FJP, Sorolla, MA, Cajal, TRY. Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/annonc.2024.05.508. PMID:. IF:65.400(Q1/1D).

01/06/2024 Preliminary results correlating post-operative ctDNA status with disease-free survival in patients with stage II (high risk)/III colorectal cancer in the BNT000-001 epidemiology study

Reinacher-Schick, AC, Lopez, MR, Alonso-Orduña, V, Lopez-Bravo, DP, Vergauwe, P, Tannapfel, A, Silveira, AB, Schlombs, K, Young, P, He, Y, Henn, H, Manning, L, Preussner, L, Mueller, F, Sahin, U, Türeci, O. Preliminary results correlating post-operative ctDNA status with disease-free survival in patients with stage II (high risk)/III colorectal cancer in the BNT000-001 epidemiology study. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families (vol 73, 103611, 2024)

Schreurs, MAC, Cajal, TRY, Adank, MA, Collée, JM, Hollestelle, A, van Rooij, J, Schmidt, MK, Hooning, MJ. The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families (vol 73, 103611, 2024). BREAST. 2024; 75DOI:10.1016/j.breast.2024.103723. PMID:. IF:7.900(Q1/1D).

01/06/2024 Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC)

Aggarwal, C, Martinez-Marti, A, Majem, M, Barlesi, F, Carcereny, E, Chu, QS, Monnet, I, Sanchez, A, Dakhil, SR, Camidge, DR, Pillet, M, Brown, M, Dowson, A, Cooper, ZA, Kumar, R, Herbst, RS. Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801

Berciano-Guerrero, MA, Perez-Ruiz, E, Couselo, EM, Manzano, JL, Cerezuela-Fuentes, P, de Miguel, PA, Soria, A, Castaño, AG, Crespo, G, Puértolas, T, De La Rosa, CA, Sanz, LG, Castro, RL, Espinosa, E, Lecumberri, MJ, Majem, M, Martinez, JM, Bellido, L, Fernández-Morales, LA, Martin-Algarra, S. Real-world effectiveness and safety of dabrafenib-trametinib as first-line of treatment for BRAF mutated metastatic melanoma: Results of the study GEM1801. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study

Martelli, V, Barrull, JV, Rodriguez, CF, Alfonso, PG, Paez, D, Gibert, J, Alonso, V, España, MAG, Vivas, CS, Ogalla, GD, Fernandez, MEE, Garcia-Carbonero, R, Monteagudo, RF, Mozo, JLM, Losa, F, Paricio, BB, Tabernero, J, Soler, RS, Aguilar, EA, Viladot, CM. Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.121. PMID:. IF:65.400(Q1/1D).

01/06/2024 Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study

Taieb, J, Fakih, M, Salvatore, L, Esaki, T, Modest, DP, Paez, D, Karamouzis, MV, Ruiz, E, Kim, TW, Kuboki, Y, Meriggi, FA, Cunningham, D, Yeh, KH, Cremolini, C, Wang, J, Tran, Q, Chao, J, Chen, Z, Pietrantonio, F. Patient-reported tolerability of sotorasib (soto) and panitumumab (pani) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in patients (pts) with metastatic colorectal cancer (mCRC) in the CodeBreaK 300 study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.043. PMID:. IF:65.400(Q1/1D).

01/06/2024 Molecular residual disease (MRD) analysis from the ADAURA trial of adjuvant (adj) osimertinib in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC)

John, T, Grohe, C, Goldman, JW, Kato, T, Laktionov, KK, Bonanno, L, Tiseo, M, Majem, M, Domine, M, Ahn, MJ, Perol, M, Hartmaier, R, Robichaux, J, Bhetariya, P, Markovets, A, Rukazenkov, Y, Muldoon, C, Herbst, RS, Tsuboi, M, Wu, YL. Molecular residual disease (MRD) analysis from the ADAURA trial of adjuvant (adj) osimertinib in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas

González-Lopez, JA, Sebio, A, Hindi, N, Jimenez, M, Villarejo-Campos, P, Martin-Broto, J, Díaz-Beveridge, R, Castellanos, JFO, Andújar, RL, Alvarez, RA, Asencio, JM, Serrano, C, Conde, NR, Boix, SC, Gimenez-Salinas, LK, Garcia, JAT, Campos, AP, Lopera, E, Bertran, J, Pousa, AL. First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

Garassino, MC, Wakelee, HA, Spicer, J, Liberman, M, Kato, T, Tsuboi, M, Lee, SH, Chen, KN, Dooms, CA, Majem, M, Eigendorff, E, Martinengo, GL, Bylicki, O, Rodriguez-Abreu, D, Chaft, JE, Yang, J, Arunachalam, A, Norquist, JM, Keller, SM, Gao, SG. Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

01/06/2024 Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study

Soler, RS, Vivas, CS, Macias, I, Esteban, AY, Bassam, A, Plazas, JG, Al-Farhat, Y, Cervantes, A, Alfonso, PG, Paez, D, Ruiz-Casado, A, Lopez, C, Arkosy, PF, Furka, A, Rodriguez-Salas, N, Pascual, FJR, Gracian, AC, Hitre, E, Monteagudo, RF, Salvia, MAS. Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.020. PMID:. IF:65.400(Q1/1D).

01/06/2024 Be aware of the X: BCOR mutations in myeloid neoplasms

Ramil, G, Pratcorona, M, Nomdedéu, JF. Be aware of the X: BCOR mutations in myeloid neoplasms. HAEMATOLOGICA. 2024; 109(6)DOI:10.3324/haematol.2023.284748. PMID:38328862. IF:10.100(Q1/2D).

01/06/2024 CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas

Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).

01/06/2024 Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis

Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).

01/06/2024 Lacrimal duct Surgery: Different Techniques and Long-Term Postoperative Results

Casasayas, M, Massegur-Solench, H, Martel-Marín, M, Kolanczak, KA, Holgado, A, Gras-Cabrerizo, JR. Lacrimal duct Surgery: Different Techniques and Long-Term Postoperative Results. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024; DOI:10.1007/s12070-024-04670-3. PMID:39376430. IF:0.054(Q4/10D).

01/06/2024 Allergy to Theobroma Cacao

Valencia, AN, Retes, LS, Bartolomé-Zavala, B, Gutiérrez, GP, Bigorra, T. Allergy to Theobroma Cacao. Clinical Case Reports. 2024; 12(6)DOI:10.1002/ccr3.8803. PMID:38883222. IF:(Q/D).

01/06/2024 Changes in prevalence and socioeconomic inequalities in secondhand smoke exposure in Spanish children, 2016-2019

Sanz-Mas, M, Continente, X, Henderson, E, Fernández, E, Schiaffino, A, Pérez-Ríos, M, Espelt, A, Guxens, M, López, MJ. Changes in prevalence and socioeconomic inequalities in secondhand smoke exposure in Spanish children, 2016-2019. Tobacco Induced Diseases. 2024; 22DOI:10.18332/tid/189392. PMID:38910916. IF:1.900(Q3/6D).

01/06/2024 Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems: A hidden enemy?

Párraga-Niño, N, Cortes-Tarragó, R, Quero, S, García-Núñez, M, Arqué, E, Sabaté, S, Ramirez, D, Gavaldá, L. Persistence of viable but nonculturable Legionella pneumophila state in hospital water systems: A hidden enemy?. The Science of the total environment. 2024; 927DOI:10.1016/j.scitotenv.2024.172410. PMID:38608884. IF:8.000(Q1/2D).

01/06/2024 Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

Gómez-Pascual A, Naccache T, Xu J, Hooshmand K, Wretlind A, Gabrielli M, Lombardo MT, Shi L, Buckley NJ, Tijms BM, Vos SJB, Ten Kate M, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleó A, Popp J, Martinez-Lage P, Streffer J, Barkhof F, Zetterberg H, Visser PJ, Lovestone S, Bertram L, Nevado-Holgado AJ, Gualerzi A, Picciolini S, Proitsi P, Verderio C, Botía JA, Legido-Quigley C. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.. COMPUTERS IN BIOLOGY AND MEDICINE. 2024; 176DOI:10.1016/j.compbiomed.2024.108588. PMID:38761503. IF:(Q/D).

01/06/2024 Trends in Sexual Health of Gay, Bisexual, and Other Men Who Have Sex with Men, and Transgender Individuals: Apps Driven Testing Program for HIV and Other STIs in Barcelona, Spain (2016-2023)

Gutiérrez, MA, Díaz, DP, Cantón, MLF, Fernández-López, L, de Olalla, PG, Gibert, CR. Trends in Sexual Health of Gay, Bisexual, and Other Men Who Have Sex with Men, and Transgender Individuals: Apps Driven Testing Program for HIV and Other STIs in Barcelona, Spain (2016-2023). JOURNAL OF COMMUNITY HEALTH. 2024; 49(3)DOI:10.1007/s10900-023-01310-9. PMID:38063976. IF:2.200(Q2/5D).

01/06/2024 BeST-Graft viewer, a new system to improve the bone allograft-recipient matching process.

Vila M, Xiberta P, Ruiz M, Bermudo R, Leivas D, Fariñas O, Vilarrodona A, Boada I. BeST-Graft viewer, a new system to improve the bone allograft-recipient matching process.. COMPUTERS IN BIOLOGY AND MEDICINE. 2024; 176DOI:10.1016/j.compbiomed.2024.108553. PMID:38723397. IF:(Q/D).

01/06/2024 Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health

Bugiardini, R, Gale, CP, Gulati, M, Anand, SS, Maas, AHEM, Townsend, N, Vaccarino, V, Badimon, L, Cenko, E, Manfrini, O, Jha, P. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health. Lancet Regional Health-Europe. 2024; 41DOI:https://ddd.uab.cat/record/324021. PMID:38725796. IF:13.000(Q1/1D).

01/06/2024 Apolipoprotein J protects cardiomyocytes from lipid-mediated inflammation and cytotoxicity induced by the epicardial adipose tissue of diabetic patients

Puig, N, Rives, J, Gil-Millan, P, Miñambres, I, Ginel, A, Tauron, M, Bonaterra-Pastra, A, Hernandez-Guillamon, M, Pérez, A, Sanchez-Quesada, L, Benitez, S. Apolipoprotein J protects cardiomyocytes from lipid-mediated inflammation and cytotoxicity induced by the epicardial adipose tissue of diabetic patients. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024; 175DOI:10.1016/j.biopha.2024.116779. PMID:38776681. IF:7.500(Q1/1D).

30/05/2024 Ten tips on how to assess bone health in patients with chronic kidney disease

Jorgensen, HS, Lloret, MJ, Lalayiannis, AD, Shroff, R, Evenepoel, P. Ten tips on how to assess bone health in patients with chronic kidney disease. Clinical Kidney Journal. 2024; 17(5)DOI:10.1093/ckj/sfae093. PMID:38817914. IF:4.600(Q1/2D).

30/05/2024 Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study)

Parker, LA, Caballero-Romeu, JP, Chilet-Rosell, E, Hernandez-Aguado, I, Gómez-Pérez, L, Alonso-Coello, P, Cebrián, A, López-Garrigós, M, Moral-Pélaez, I, Ronda, E, Gilabert, M, Canelo-Aybar, C, Párraga-Martínez, I, del Campo-Giménez, M, Lumbreras, B. Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). PLoS One. 2024; 19(5)DOI:10.1371/journal.pone.0303203. PMID:38814917. IF:2.600(Q2/4D).

29/05/2024 miRNA signature related to atherosclerotic lesion induced shear stress modifications in familial hypercholesterolemia patients with subclinical atherosclerosis: a bioinformatics systems biology study

Padro, T, Escate, R, De Isla, LP, Muniz-Grijalbo, O, Mata, P, Badimon, L. miRNA signature related to atherosclerotic lesion induced shear stress modifications in familial hypercholesterolemia patients with subclinical atherosclerosis: a bioinformatics systems biology study. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.170. PMID:. IF:13.300(Q1/1D).

29/05/2024 Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor

Pardo, IC, Botija, BP, Garcia, AG, Villanueva, LO, Folgado, IM, Raposo,, Mur, S, Robles,, Gil, JCE, Nunez, E, Sancho, D, Vazquez, J, Colio, LMB, Ramiro, A, Ventura, JLM. Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.161. PMID:. IF:13.300(Q1/1D).

29/05/2024 Role of polymeric immunoglobulin receptor in glucose metabolism

Botija, MP, Pardo, IC, Garcia, AG, Villanueva, LO, Colio, LB, Ramiro, A, Gil, JCE, Ventura, JLM. Role of polymeric immunoglobulin receptor in glucose metabolism. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.192. PMID:. IF:13.300(Q1/1D).

27/05/2024 Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration

Tappero, S, Bravi, CA, Khene, ZE, Campi, R, Pecoraro, A, Diana, P, Re, C, Giulioni, C, Beksac, AT, Bertolo, R, Ajami, T, Okhawere, KE, Meagher, M, Alimohammadi, A, Terrone, C, Mari, A, Amparore, D, Da Pozzo, L, Anceschi, U, Suardi, N, Galfano, A, Larcher, A, Schiavina, R, Canda, E, Zhang, X, Shariat, S, Porpiglia, F, Antonelli, A, Kaouk, J, Badani, K, Derweesh, I, Breda, A, Mottrie, A, Dell'Oglio, P. Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration. ANNALS OF SURGICAL ONCOLOGY. 2024; DOI:10.1245/s10434-024-15305-w. PMID:38802714. IF:3.500(Q1/2D).

24/05/2024 PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI

de Rooij, M, Allen, C, Twilt, JJ, Thijssen, LCP, Asbach, P, Barrett, T, Brembilla, G, Emberton, M, Gupta, RT, Haider, MA, Kasivisvanathan, V, Logager, V, Moore, CM, Padhani, AR, Panebianco, V, Puech, P, Purysko, AS, Renard-Penna, R, Richenberg, J, Salomon, G, Sanguedolce, F, Schoots, IG, Thöny, HC, Turkbey, B, Villeirs, G, Walz, J, Barentsz, J, Giganti, F. PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. EUROPEAN RADIOLOGY. 2024; 34(11)DOI:10.1007/s00330-024-10795-4. PMID:38787428. IF:4.700(Q1/2D).

24/05/2024 Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes

Quirós, C, Arranz, MTH, Amigó, J, Wägner, AM, Beato-Vibora, PI, Azriel-Mira, S, Climent, E, Soldevila, B, Barquiel, B, Colomo, N, Durán-Martínez, M, Corcoy, R, Codina, M, Díaz-Soto, G, Pardo, RM, Martínez-Brocca, MA, Roman, AR, López-Gallardo, G, Cuesta, M, Fernández, JG, Goya, M, Guedes, BV, Mathison, LCM, Perea, V. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes. Diabetes Technology & Therapeutics. 2024; DOI:10.1089/dia.2023.0594. PMID:38417014. IF:6.300(Q1/2D).

23/05/2024 Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV

Benito-Garcia, S, Vilardell, J, Arce, Y, Barros, X, Marco, H, Guirado, L, Encarnacion, MMD. Fibrosis and CD-163+macrophages: making a difference between MPO-AAV and PR3-AAV. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.324. PMID:. IF:5.600(Q1/1D).

23/05/2024 Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis

Delgado, CM, Rodríguez, DL, Navarro-González, JF, Henriquez, F, Gilsanz, GD, Prieto, FJT, Jesus, LM, Morales, OS, Macia, M. Comparative analysis of vitamin D status between patients with advanced chronic kidney disease and those on dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1481. PMID:. IF:5.600(Q1/1D).

23/05/2024 ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis

Jiménez, EM, Sanjuan, JB, Casado, E, García, MR, Lloret, MJ, Alonso, CC, Henriquez, F, Gifre, L, Calvo, JAH, Teruel, JLG, Gómez, C, Navarro-González, JF. ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.1471. PMID:. IF:5.600(Q1/1D).

23/05/2024 Impact of dialysis modality on bone phenotype

Lloret, MJ, Jorgensen, HS, Verhulst, A, Bammens, B, Claes, K, Devusser, K, Meijers, B, Van Craenenbroeck, A, De Loor, J, Cavalier, E, Evenepoel, P. Impact of dialysis modality on bone phenotype. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.856. PMID:. IF:5.600(Q1/1D).

23/05/2024 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)

Brigl, C, Münster, J, Arjune, S, Demoulin, N, Gansevoort, R, Torra, R, Sans, L, Pamplona, IA, Sayer, J, Cornec-Le Gall, E, Hwang, DY, Halbritter, J. Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*). NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024; 39DOI:10.1093/ndt/gfae069.005. PMID:. IF:5.600(Q1/1D).

23/05/2024 The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma

Agache, I, Ricci-Cabello, I, Canelo-Aybar, C, Annesi-Maesano, I, Cecchi, L, Biagioni, B, Chung, KF, D'Amato, G, Damialis, A, del Giacco, S, de las Vecillas, L, Dominguez-Ortega, J, Galán, C, Gilles, S, Giovannini, M, Holgate, S, Jeebhay, M, Nadeau, K, Papadopoulos, N, Quirce, S, Sastre, J, Traidl-Hoffmann, C, Walusiak-Skorupa, J, Salazar, J, Sousa-Pinto, B, Colom, M, Fiol-deRoque, MA, López, LG, Malih, N, Moro, L, Pardo, MG, Pazo, PG, Campos, RZ, Saletti-Cuesta, L, Akdis, M, Alonso-Coello, P, Jutel, M, Akdis, CA. The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma. ALLERGY. 2024; 79(9)DOI:10.1111/all.16151. PMID:38783343. IF:12.000(Q1/1D).